13F Pro

SEC Form 4 reporting owner

Sanofi

Sanofi has filed 8 Form 4 transactions reported between August 6, 2026 and August 10, 2026, as a reporting owner of Latigo Biotherapeutics, Inc., a reporting owner of Sanofi and a reporting owner of Attovia Therapeutics, Inc..

Name as filed: Sanofi

Open-market buys, 24 mo
$5.1M
1 lines
Open-market sales, 24 mo
None
reported
Companies
3
with Form 4 filings
Latest transaction
Aug 10, 2026
transaction date

Roles and reported holdings

  • LTGOLatigo Biotherapeutics, Inc.
    Aug 10, 2026

    Reporting owner

    No common-stock holding reported on a purchase, sale, gift or withholding line.

  • SNYSanofi
    Aug 6, 2026 – Aug 10, 2026

    Reporting owner

    No common-stock holding reported on a purchase, sale, gift or withholding line.

    1 line is priced far from SNY’s market price that day, so the filing may concern a different security. Left out of totals and holdings; see the filings.

  • ATTOAttovia Therapeutics, Inc.
    Aug 6, 2026

    Reporting owner

    Held indirectly (latest line)1,082,855 sh as of Aug 6, 2026 · Form 4

    24 months: $5.1M bought

Transaction history

All 8 reported transactions, newest first. Every row links to the Form 4 on SEC EDGAR.

DateCompanyTypeSharesValueFiling
Aug 10, 2026LTGOConversion of derivativeCode C · indirect177,978—Form 4
Aug 10, 2026LTGOConversion of derivativeCode C · indirect494,800—Form 4
Aug 10, 2026SNYConversion of derivativeCode C · indirect177,978—Form 4
Aug 10, 2026SNYConversion of derivativeCode C · indirect494,800—Form 4
Aug 6, 2026ATTOOpen-market purchaseCode P · indirect300,000$5.1M@ $17.00Form 4
Aug 6, 2026ATTOConversion of derivativeCode C · indirect782,855—Form 4
Aug 6, 2026SNYOpen-market purchaseCode P · indirectPrice far from market; may be another security300,000$5.1M@ $17.00Form 4
Aug 6, 2026SNYConversion of derivativeCode C · indirect782,855—Form 4

How this page is built

Every row comes from a Form 4 filed with the SEC, which officers, directors and holders of more than 10% of a company’s stock must file within two business days of a trade. Transactions are grouped by the reporting owner’s name as filed (spacing, capitals and punctuation ignored); two different people filing under an identical name would appear together, and one person filing under two spellings appears on two pages.

Open-market totals count code P purchases and code S sales over the last 24 months. The same trade reported on more than one filing is counted once; when another owner (for example a fund and its general partner) reports the identical trade, they are listed beside it. Holdings are the shares owned after the latest purchase, sale, gift or tax-withholding line, shown separately for direct and indirect ownership; an indirect figure is one holding line, not a total across every trust or entity.

1 open-market line is priced outside 0.67×–1.5× of the stock’s closing price that day. A gap that large usually means the filing reports a different security than the company it is filed under, so those lines are shown but left out of totals and holdings.

This page describes what was filed with the SEC; it is not investment advice or a recommendation to buy or sell any security.